ReNeuron Group plc (AIM: RENE), a UK-based leader in stem cell derived exosome technologies, announces the appointment of John Hawkins, ACA, as Chief Financial Officer (‘CFO’) and ReNeuron Board member with immediate effect. The Group is also pleased to announce that Simon Dew will be joining the Executive Team as Chief Business Officer (‘CBO’).
Additionally, the Group is making changes to the Executive team.